Metropolitan Life Insurance Company (MetLife)’s Veritone VERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,716
Closed -$10K 2522
2023
Q1
$10K Buy
1,716
+106
+7% +$729 ﹤0.01% 2160
2022
Q4
$8.53K Hold
1,610
﹤0.01% 2319
2022
Q3
$9.06K Hold
1,610
﹤0.01% 2290
2022
Q2
$10.5K Hold
1,610
﹤0.01% 2304
2022
Q1
$29.4K Sell
1,610
-5,726
-78% -$98.5K ﹤0.01% 1898
2021
Q4
$165K Hold
7,336
﹤0.01% 2153
2021
Q3
$175K Hold
7,336
﹤0.01% 2180
2021
Q2
$145K Hold
7,336
﹤0.01% 2386
2021
Q1
$176K Hold
7,336
﹤0.01% 2111
2020
Q4
$209K Buy
+7,336
New +$127K ﹤0.01% 1912
2020
Q3
Sell
-7,357
Closed -$109K 2594
2020
Q2
$109K Buy
+7,357
New +$61.8K ﹤0.01% 2202

Other funds holding VERI

Metropolitan Life Insurance Company (MetLife)'s VERI Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Veritone (VERI) in Q2 2023, closing a stake of 1,716 shares — an estimated $10K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VERI in Q2 2020 and held it in 11 quarters. The position peaked at $209K in Q4 2020. 72 funds tracked by Wall St. Rank hold VERI as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Veritone position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,716 Veritone shares in Q2 2023, an estimated $10K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Veritone in Q2 2020 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Veritone position peaked at $209K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Veritone as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.